BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Distributed Bio

Distributed Bio logo


Distributed Bio is an immuno-engineering company that provides computational tools, antibody libraries, and more. The company's mission is to develop breakthrough technologies to drug previously challenging targets like GPCRs, ion channels, pMHC complexes, condition-specific binders, anti-idiotypes, and broadly neutralizing viral epitopes. The combination of computational immunology, bioengineering, and robotics has allowed the company to develop a pipeline of molecules with unprecedented biophysical properties, while also supporting all of the partners with thousands of high affinity developable antibodies against any drug target of interest.

Distributed Bio was founded on 2010 and is headquartered in San Francisco, California.

Posts Mentioning This Company

How Pharma Reacts To Wuhan Coronavirus Outbreak

UPDATE April 04. 2020. The number of confirmed cases of COVID19 approaches 1M globally. Since too many drug repurposing programs and vaccine development projects have been urgently initiated, we decided to summarize them in a separate post: A Running List Of COVID-19 Treatments And Vaccines In Development With this, we …